This HTML5 document contains 111 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

Prefix	IRI
wdt	http://www.wikidata.org/prop/direct/
wdtn	http://www.wikidata.org/prop/direct-normalized/
schema	http://schema.org/
rdfs	http://www.w3.org/2000/01/rdf-schema#
skos	http://www.w3.org/2004/02/skos/core#
wikibase	http://wikiba.se/ontology#
p	http://www.wikidata.org/prop/
n8	http://dx.doi.org/10.1200/
rdf	http://www.w3.org/1999/02/22-rdf-syntax-ns#
n12	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdh	http://www.w3.org/2001/XMLSchema#
wds	http://www.wikidata.org/entity/statement/
wd	http://www.wikidata.org/entity/

Statements

Subject Item

wd:Q35208736

rdf:type

wikibase:Item

schema:description

articolo scientifico 2003年论文 наукова стаття, опублікована у вересні 2003 мақолаи илмӣ vetenskaplig artikel επιστημονικό άρθρο 2003年論文 2003年の論文 научни чланак artículo científico publicado en 2003 2003年论文 vitenskapelig artikkel artículu científicu espublizáu en 2003 научна статия 2003年论文 vedecký článok scienca artikolo scientific article บทความทางวิทยาศาสตร์ 2003年论文 article scientific naučni članak vědecký článek სამეცნიერო სტატია 2003 nî lūn-bûn artigo científico (publicado na 2003) 2003年論文 bilimsel makale ২০০৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vitskapeleg artikkel سائنسی مضمون artikulong pang-agham مقالهٔ علمی tieteellinen artikkeli wissenschaftlicher Artikel article scientifique (publié 2003) article científic мақолаи илмӣ مقالة علمية научни чланак articol științific wetenschappelijk artikel 2003年論文 bài báo khoa học 2003 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած 2003年论文 2003年論文 artykuł naukowy מאמר מדעי artigo científico (publicado na 2003) 2003年论文 2003 թվականի սեպտեմբերին հրատարակված գիտական հոդված 2003년 논문 videnskabelig artikel (udgivet 2003) mokslinis straipsnis artikull shkencor научная статья tudományos cikk artigo científico teaduslik artikkel 2003年論文

p:P577

wds:Q35208736-E7B2CE37-FCDB-48E7-ACB3-DDD3AE6565C4

wdt:P577

2003-09-01T00:00:00Z

p:P407

wds:Q35208736-975A8F7B-841C-45BB-AAB2-9A4601893AA1

wdt:P407

wd:Q1860

p:P2093

wds:Q35208736-09FDD8B2-93A3-4224-818E-D05DFE48401D wds:Q35208736-86682717-404A-4884-B092-42B7A3B7B444 wds:Q35208736-D2F589EB-514D-47A9-AADD-F09978A45397 wds:Q35208736-DDFF3086-CC9D-46F4-B2D2-248780D9D45B wds:Q35208736-D53E23F6-4E8B-4BE1-AAB3-8E6B373BCFE5

wdt:P2093

Bettina Müller Neuro-Oncology Working Group of the German Cancer Society Rainer Koch Michael Bamberg Peter Krauseneck

rdfs:label

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

skos:prefLabel

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

schema:name

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

p:P50

wds:Q35208736-E137B98D-F258-4458-8D3F-DC1633E96F80

wdt:P50

wd:Q2779469

p:P1476

wds:Q35208736-C0481811-067B-48F1-AA0D-159062213535

wdt:P1476

Neuro-Oncology Working Group 01 trial of nimustine plus teniposide versus nimustine plus cytarabine chemotherapy in addition to involved-field radiotherapy in the first-line treatment of malignant glioma

p:P304

wds:Q35208736-6A5D58FE-D04B-4BBA-B57D-7C99332444BC

wdt:P304

3276-3284

p:P31

wds:Q35208736-6CC85A29-79CB-4099-844B-F0D4443A6F13

wdt:P31

wd:Q13442814

p:P921

wds:Q35208736-E7996ABD-F270-4FBC-8556-DD089E328D5B wds:Q35208736-DAA4C31E-CE17-407A-94DC-C5988F9E6B47 wds:Q35208736-23C11393-2E62-41A7-9A95-218ED964DE64

wdt:P921

wd:Q180983 wd:Q974135 wd:Q180507

p:P698

wds:Q35208736-FA46BA12-A900-46AF-99D5-1DA2D77FE253

wdtn:P698

n12:12947063

wdt:P698

12947063

p:P1433

wds:Q35208736-708AC129-E188-4E09-9770-924E02ABAF96

wdt:P1433

wd:Q400292

p:P433

wds:Q35208736-ECD436EA-BAB7-4051-9D47-E7EC615BB219

p:P478

wds:Q35208736-A10FA732-B127-411F-9790-B8FFBB052CF1

wdt:P433

17

wdt:P478

21

p:P356

wds:Q35208736-128026A0-86B8-4C10-9BE7-A48C67589ABA

wdtn:P356

n8:JCO.2003.03.509

wdt:P356

10.1200/JCO.2003.03.509